Retatrutide 40mg/3ml

What is Retatrutide (RETA)?

Retatrutide is a next-generation investigational peptide and one of the most talked-about compounds in metabolic research today. As a triple-hormone receptor agonist, it simultaneously targets GLP-1, GIP, and glucagon receptors — a unique triple-action mechanism that sets it apart from other peptides in its class.

Imagine a single compound working across three distinct pathways at once: curbing appetite, enhancing insulin sensitivity, and ramping up energy expenditure. That's the promise researchers are exploring with Retatrutide.

Mechanism of Action

By engaging three key metabolic receptors, Retatrutide is being studied for its potential to influence:

• GLP-1 receptor activation — supports satiety signaling and slows gastric emptying
• GIP receptor activation — enhances insulin response and may improve fat metabolism
• Glucagon receptor activation — promotes energy expenditure and caloric utilization

Areas of Research

Current clinical and preclinical studies are evaluating Retatrutide's potential role in:

• Body weight regulation and obesity management
• Glucose metabolism and insulin sensitivity
• Metabolic function and energy balance
• Appetite control and food intake reduction

Research Use Only

This product is intended for laboratory research purposes only. It is not intended for human consumption, medical use, diagnosis, cure, mitigation, treatment, or prevention of any disease. This product has not been evaluated by the U.S. Food and Drug Administration (FDA). Purchasers are responsible for compliance with all applicable laws and regulations regarding the use and handling of research materials.